NRT6008

· Chengdu New Radiomedicine Technology Co. LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NRT6008, covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) [Phase 1]